Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
Natasha Mesinkovska, Brett King, Xingqi Zhang, Emma Guttman-Yassky, Nina Magnolo, Rodney Sinclair, Masato Mizuashi, Jerry Shapiro, Elena Peeva, Anindita Banerjee, Liza Takiya, Lori Ann Cox, Dalia Wajsbrot, Urs Kerkmann, Ernest Law, Robert Wolk, Gregor Schaefer
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis'. Together they form a unique fingerprint.